| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $1.8M | -17.9% |
| R&D Expense | $191.6M | +73.9% |
| SG&A Expense | $29.4M | +39.1% |
| Operating Income | -$219.2M | -69.8% |
| Pre-tax Income | -$239.7M | -65.1% |
| Income Tax | $3K | +0.0% |
| Net Income | -$241.4M | -66.2% |
| EPS (Basic) | -$5.12 | -41.4% |
| EPS (Diluted) | -$5.12 | -41.4% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $277.9M | +1.5% |
| Current Assets | $295.4M | +5.3% |
| Total Assets | $307.9M | +5.9% |
| Current Liabilities | $56.3M | +104.2% |
| Total Liabilities | $264.4M | +13.6% |
| Stockholders' Equity | $43.5M | -25.1% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$193.3M | -67.7% |
| Capital Expenditures | $4.6M | +569.5% |
| Investing Cash Flow | -$4.6M | -569.5% |
| Financing Cash Flow | $202.0M | -21.9% |
| Free Cash Flow | -$197.9M | -70.6% |